The following 16 images provide visual information about the product associated with Fluticasone Propionate And Salmeterol Diskus NDC 53002-1568 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Fluticasone propionate chemical structure - fp sal spl graphic 01
Salmeterol xinafoate chemical structure - fp sal spl graphic 02
Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects with Asthma Previously Treated with Either Inhaled Corticosteroids or Salmeterol (Trial 1) - fp sal spl graphic 03
Figure 2. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - fp sal spl graphic 04
Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - fp sal spl graphic 05
Figure 4. Predose FEV1: Mean Percent Change from Baseline in Subjects with Chronic Obstructive Pulmonary Disease - fp sal spl graphic 06
Figure 5. Two-Hour Postdose FEV1: Mean Percent Changes from Baseline over Time in Subjects with Chronic Obstructive Pulmonary Disease - fp sal spl graphic 07
Figure A - fp sal spl graphic 08
Figure B - fp sal spl graphic 09
Figure C - fp sal spl graphic 10
Figure D - fp sal spl graphic 11
Figure E - fp sal spl graphic 12
Figure F - fp sal spl graphic 13
Figure G - fp sal spl graphic 14
Figure H - fp sal spl graphic 15
Label Image - lbl530021568